Switzerland
# |
Name |
EBITDA |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 21.87 B
|
Dec. 31, 2023 | USD 333.72 | 0.27% |
|
Switzerland |
|
2 |
USD 20.71 B
|
Dec. 31, 2024 | USD 104.72 | -0.12% |
|
Switzerland |
|
3 |
USD 1.13 B
|
Dec. 31, 2024 | USD 651.30 | 2.02% |
|
Switzerland |
|
4 |
USD 857.00 M
|
Dec. 31, 2023 | USD 46.21 | -3.47% |
|
Switzerland |
|
5 |
USD 597.28 M
|
Dec. 31, 2023 | USD 138.90 | -2.86% |
|
Switzerland |
|
6 |
USD 364.54 M
|
Dec. 31, 2023 | USD 88.99 | -0.28% |
|
Switzerland |
|
7 |
USD 286.50 M
|
Dec. 31, 2023 | USD 1.12 K | -0.26% |
|
Switzerland |
|
8 |
USD 244.17 M
|
Dec. 31, 2023 | USD 250.45 | -3.26% |
|
Switzerland |
|
9 |
USD 193.93 M
|
Dec. 31, 2023 | USD 62.45 | -2.60% |
|
Switzerland |
|
10 |
USD 179.33 M
|
March 31, 2024 | USD 382.54 | -3.00% |
|
Switzerland |
|
11 |
USD 132.06 M
|
Dec. 31, 2023 | USD 126.21 | -1.33% |
|
Switzerland |
|
12 |
USD 94.04 M
|
Dec. 31, 2023 | USD 17.87 | -4.83% |
|
Switzerland |
|
13 |
USD 84.80 M
|
Dec. 31, 2023 | USD 13.36 | -0.81% |
|
Switzerland |
|
14 |
USD 58.27 M
|
Dec. 31, 2023 | USD 15.53 | -0.65% |
|
Switzerland |
|
15 |
USD 51.94 M
|
Dec. 31, 2023 | USD 1.14 K | -1.12% |
|
Switzerland |
|
16 |
USD 37.18 M
|
Dec. 31, 2023 | USD 3.57 | -5.82% |
|
Switzerland |
|
17 |
USD 29.33 M
|
Dec. 31, 2023 | USD 74.55 | -2.22% |
|
Switzerland |
|
18 |
USD 28.27 M
|
Dec. 31, 2023 | USD 60.16 | -1.72% |
|
Switzerland |
|
19 |
USD 27.75 M
|
Dec. 31, 2023 | USD 161.30 | -1.97% |
|
Switzerland |
|
20 |
USD 27.54 M
|
Dec. 31, 2023 | USD 43.76 | -1.99% |
|
Switzerland |
|
21 |
USD -12.36 M
|
Dec. 31, 2023 | USD 24.30 | -3.46% |
|
Switzerland |
|
22 |
USD -24.45 M
|
Dec. 31, 2023 | USD 27.36 | -2.78% |
|
Switzerland |
|
23 |
USD -54.11 M
|
Dec. 31, 2023 | USD 45.99 | -2.40% |
|
Switzerland |
|
24 |
USD -61.56 M
|
Dec. 31, 2023 | USD 2.75 | 1.85% |
|
Switzerland |
|
25 |
USD -64.81 M
|
Dec. 31, 2023 | USD 21.72 | -0.35% |
|
Switzerland |
|
26 |
USD -70.69 M
|
Dec. 31, 2023 | USD 5.05 | -4.17% |
|
Switzerland |
|
27 |
USD -146.76 M
|
Dec. 31, 2023 | USD 1.68 | -2.33% |
|
Switzerland |
|
28 |
USD -202.70 M
|
Dec. 31, 2023 | USD 41.59 | -1.07% |
|
Switzerland |
The Healthcare company in Switzerland with the highest EBITDA is Roche Holding AG (Swiss Stock Exchange: RO.SW) at USD 21.87 B.
The Healthcare company in Switzerland with the lowest EBITDA is CRISPR Therapeutics AG (NasdaqGM: CRSP) at USD -202.70 M.
The top 10 Healthcare companies in Switzerland by EBITDA are Roche Holding AG, Novartis AG, Lonza Group AG, Sandoz Group AG, Straumann Holding AG, Galenica AG, Siegfried Holding AG, Tecan Group AG, Bachem Holding AG and Ypsomed Holding AG.
The bottom 10 Healthcare companies in Switzerland by EBITDA are CRISPR Therapeutics AG, ADC Therapeutics SA, Molecular Partners AG, DocMorris AG, AC Immune SA, MoonLake Immunotherapeutics, PolyPeptide Group AG, Kuros Biosciences AG, Basilea Pharmaceutica AG and IVF Hartmann Holding AG.